Correspondingly, both serum Se and selenoprotein P (SELENOP) levels were found to be lower in COVID-19 patients with low values (<2.5 of the reference population) observed in 43.4% and 39.2% cases, respectively. The gene discussed is SELENOP; the disease is COVID-19.